ArticleTheranostics2020

Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.

Charvi Syal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.